Cargando…

Targeted In Vivo Inhibition of Specific Protein–Protein Interactions Using Recombinant Antibodies

With the growing availability of genomic sequence information, there is an increasing need for gene function analysis. Antibody-mediated “silencing” represents an intriguing alternative for the precise inhibition of a particular function of biomolecules. Here, we describe a method for selecting reco...

Descripción completa

Detalles Bibliográficos
Autores principales: Zábrady, Matej, Hrdinová, Vendula, Müller, Bruno, Conrad, Udo, Hejátko, Jan, Janda, Lubomír
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4192540/
https://www.ncbi.nlm.nih.gov/pubmed/25299686
http://dx.doi.org/10.1371/journal.pone.0109875
_version_ 1782338797196804096
author Zábrady, Matej
Hrdinová, Vendula
Müller, Bruno
Conrad, Udo
Hejátko, Jan
Janda, Lubomír
author_facet Zábrady, Matej
Hrdinová, Vendula
Müller, Bruno
Conrad, Udo
Hejátko, Jan
Janda, Lubomír
author_sort Zábrady, Matej
collection PubMed
description With the growing availability of genomic sequence information, there is an increasing need for gene function analysis. Antibody-mediated “silencing” represents an intriguing alternative for the precise inhibition of a particular function of biomolecules. Here, we describe a method for selecting recombinant antibodies with a specific purpose in mind, which is to inhibit intrinsic protein–protein interactions in the cytosol of plant cells. Experimental procedures were designed for conveniently evaluating desired properties of recombinant antibodies in consecutive steps. Our selection method was successfully used to develop a recombinant antibody inhibiting the interaction of ARABIDOPSIS HISTIDINE PHOSPHOTRANSFER PROTEIN 3 with such of its upstream interaction partners as the receiver domain of CYTOKININ INDEPENDENT HISTIDINE KINASE 1. The specific down-regulation of the cytokinin signaling pathway in vivo demonstrates the validity of our approach. This selection method can serve as a prototype for developing unique recombinant antibodies able to interfere with virtually any biomolecule in the living cell.
format Online
Article
Text
id pubmed-4192540
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-41925402014-10-14 Targeted In Vivo Inhibition of Specific Protein–Protein Interactions Using Recombinant Antibodies Zábrady, Matej Hrdinová, Vendula Müller, Bruno Conrad, Udo Hejátko, Jan Janda, Lubomír PLoS One Research Article With the growing availability of genomic sequence information, there is an increasing need for gene function analysis. Antibody-mediated “silencing” represents an intriguing alternative for the precise inhibition of a particular function of biomolecules. Here, we describe a method for selecting recombinant antibodies with a specific purpose in mind, which is to inhibit intrinsic protein–protein interactions in the cytosol of plant cells. Experimental procedures were designed for conveniently evaluating desired properties of recombinant antibodies in consecutive steps. Our selection method was successfully used to develop a recombinant antibody inhibiting the interaction of ARABIDOPSIS HISTIDINE PHOSPHOTRANSFER PROTEIN 3 with such of its upstream interaction partners as the receiver domain of CYTOKININ INDEPENDENT HISTIDINE KINASE 1. The specific down-regulation of the cytokinin signaling pathway in vivo demonstrates the validity of our approach. This selection method can serve as a prototype for developing unique recombinant antibodies able to interfere with virtually any biomolecule in the living cell. Public Library of Science 2014-10-09 /pmc/articles/PMC4192540/ /pubmed/25299686 http://dx.doi.org/10.1371/journal.pone.0109875 Text en © 2014 Zábrady et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Zábrady, Matej
Hrdinová, Vendula
Müller, Bruno
Conrad, Udo
Hejátko, Jan
Janda, Lubomír
Targeted In Vivo Inhibition of Specific Protein–Protein Interactions Using Recombinant Antibodies
title Targeted In Vivo Inhibition of Specific Protein–Protein Interactions Using Recombinant Antibodies
title_full Targeted In Vivo Inhibition of Specific Protein–Protein Interactions Using Recombinant Antibodies
title_fullStr Targeted In Vivo Inhibition of Specific Protein–Protein Interactions Using Recombinant Antibodies
title_full_unstemmed Targeted In Vivo Inhibition of Specific Protein–Protein Interactions Using Recombinant Antibodies
title_short Targeted In Vivo Inhibition of Specific Protein–Protein Interactions Using Recombinant Antibodies
title_sort targeted in vivo inhibition of specific protein–protein interactions using recombinant antibodies
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4192540/
https://www.ncbi.nlm.nih.gov/pubmed/25299686
http://dx.doi.org/10.1371/journal.pone.0109875
work_keys_str_mv AT zabradymatej targetedinvivoinhibitionofspecificproteinproteininteractionsusingrecombinantantibodies
AT hrdinovavendula targetedinvivoinhibitionofspecificproteinproteininteractionsusingrecombinantantibodies
AT mullerbruno targetedinvivoinhibitionofspecificproteinproteininteractionsusingrecombinantantibodies
AT conradudo targetedinvivoinhibitionofspecificproteinproteininteractionsusingrecombinantantibodies
AT hejatkojan targetedinvivoinhibitionofspecificproteinproteininteractionsusingrecombinantantibodies
AT jandalubomir targetedinvivoinhibitionofspecificproteinproteininteractionsusingrecombinantantibodies